BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,994 Cr | ₹4,061 Cr | ₹2,954 Cr | ₹1,853 Cr | ₹1,177 Cr |
What is the latest Cash Flow from Operating Activities ratio of BIOCON ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,994 Cr |
| Mar2025 | ₹4,061 Cr |
| Mar2024 | ₹2,954 Cr |
| Mar2023 | ₹1,853 Cr |
| Mar2022 | ₹1,177 Cr |
How is Cash Flow from Operating Activities of BIOCON Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,994 Cr | -50.90 | |
| Mar2025 | ₹4,061 Cr | 37.49 | |
| Mar2024 | ₹2,954 Cr | 59.45 | |
| Mar2023 | ₹1,853 Cr | 57.45 | |
| Mar2022 | ₹1,177 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹57,039.5 Cr | 1.4% | -6.4% | -0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 1.4% |
-6.4% |
-0.4% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses